| JPH08505397A (en)* | 1993-01-07 | 1996-06-11 | トーマス ジェファーソン ユニバーシティ | Antisense inhibition of c-myc to regulate smooth muscle cell proliferation. |
| US6133242A (en)* | 1993-10-15 | 2000-10-17 | Thomas Jefferson Univerisity | Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
| US6323184B1 (en) | 1993-10-15 | 2001-11-27 | Thomas Jefferson University | Arteriovenous and venous graft treatments: methods and compositions |
| US5656612A (en)* | 1994-05-31 | 1997-08-12 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
| US6410518B1 (en) | 1994-05-31 | 2002-06-25 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide inhibition of raf gene expression |
| US6090626A (en)* | 1994-05-31 | 2000-07-18 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide modulation of raf gene expression |
| US6358932B1 (en) | 1994-05-31 | 2002-03-19 | Isis Pharmaceticals, Inc. | Antisense oligonucleotide inhibition of raf gene expression |
| KR100211178B1 (en)* | 1994-05-31 | 1999-07-15 | 파샬 비. 린네 | Antisense Oligonucleotide Regulation of Rafgene Expression |
| US5744362A (en)* | 1994-05-31 | 1998-04-28 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
| WO1997032604A1 (en)* | 1996-03-07 | 1997-09-12 | Novartis Ag | Antiproliferative combinations, containing raf-targeted oligonucleotides and chemotherapeutic compounds |
| US5744460A (en)* | 1996-03-07 | 1998-04-28 | Novartis Corporation | Combination for treatment of proliferative diseases |
| US6803360B1 (en) | 1996-12-30 | 2004-10-12 | Georgetown University | Compositions and methods for reducing radiation and drug resistance in cells |
| US7262173B2 (en) | 1997-03-21 | 2007-08-28 | Georgetown University | Chemosensitizing with liposomes containing oligonucleotides |
| EP1173254A2 (en)* | 1999-04-27 | 2002-01-23 | Smithkline Beecham Plc | Novel treatment of neurotraumatic conditions with a raf inhibitor |
| PT1309726E (en) | 2000-03-30 | 2010-03-08 | Whitehead Biomedical Inst | RNA INTERFERENCE-SPECIFIC RNA INTERFERENCE MEDIATORS |
| DE10020138A1 (en)* | 2000-04-14 | 2001-10-31 | Ulf R Rapp | Nucleic acid coding for at least one partial sequence with a MEKK1 binding site |
| CA2429814C (en) | 2000-12-01 | 2014-02-18 | Thomas Tuschl | Rna interference mediating small rna molecules |
| WO2002081642A2 (en) | 2001-04-06 | 2002-10-17 | Georgetown University | Gene brcc-3 and diagnostic and therapeutic uses thereof |
| WO2002081639A2 (en) | 2001-04-06 | 2002-10-17 | Georgetown University | Gene brcc2 and diagnostic and therapeutic uses thereof |
| AU2002305151A1 (en) | 2001-04-06 | 2002-10-21 | Georgetown University | Gene scc-112 and diagnostic and therapeutic uses thereof |
| US7138512B2 (en) | 2002-04-10 | 2006-11-21 | Georgetown University | Gene SHINC-2 and diagnostic and therapeutic uses thereof |
| US7244565B2 (en) | 2002-04-10 | 2007-07-17 | Georgetown University | Gene shinc-3 and diagnostic and therapeutic uses thereof |
| US20050148528A1 (en)* | 2002-05-20 | 2005-07-07 | Neopharm, Inc | Method for reducing platelet count |